中华临床医师杂志(电子版) 2017年2月,11卷4期

临床论著

原发性高血压患者血清总胆红素水平与左心室肥厚的相关性研究

梁金花1 冯颖妍1 冯志仪1 周祖勇2 周红辉3

529700 广东省,鹤山市人民医院彩超中心1,心内科2,检验科
梁金花,Email: zzy941157@sina.com

摘要:目的 分析初诊或未治疗的原发性高血压患者血清总胆红素水平与左心室肥厚的关系。方法 选取2015年1至8月在鹤山市人民医院就诊资料完整的新发原发性高血压患者200例,根据左心室质量指数分为左心室肥厚组(58例)及左心室正常组(142例)。比较两组患者的一般临床资料、生化指标和超声心动图参数,并采用单因素和多因素回归分析左心室肥厚的相关因素。结果 在原发性高血压患者中,左心室肥厚组血清总胆红素水平明显低于左心室正常组[(22.47±6.75)U/L vs.(33.24±5.84)U/L],单因素分析结果表明,收缩压(OR=1.569,95% CI 1.125~2.896;P=0.002)和年龄(OR=1.372,95% CI 1.103~1.925;P=0.047)是左心室肥厚的危险因素,而血清总胆红素(OR=0.586,95% CI 0.259~0.852;P=0.001)是左心室肥厚的保护因素,进一步多因素Logistic回归分析表明,血清总胆红素(OR=0.459,95% CI 0.231~0759;P=0.018)仍是左心室肥厚的保护因素。结论 原发性高血压患者血清总胆红素是左心室肥厚的保护因素,监测血清总胆红素变化可能对早期发现左心室重构有一定意义。

关键词:高血压; 胆红素; 肥大,左心室

Relationship between serum total bilirubin levels and left ventricular hypertrophy in patients with essential hypertension

Liang Jinhua1, Feng Yingyan1, Feng Zihiyi1, Zhou Zuyong2, Zhou Honghui3

The Center of Color Ultrasound, 2Department of Cardiology, 3Department of Laboratory, Heshan People's Hospital, Heshan 529700, China
Liang Jinhua, Email: zzy941157@sina.com

Abstract:Objective To analyze the relationship between serum total bilirubin level and left ventricular hypertrophy in essential hypertension patients newly diagnosed or untreatment. Methods Two hundred newly diagnosed essential hypertension patients were from Heshan People's Hospital from January 2015 to August 2015. They were divided into none left ventricular hypertrophy (142 cases) and left ventricular hypertrophy group (58 cases) based on left ventricular mass index. The clinical data, biochemical indicators and ultrasonic cardiogram parameters between groups were compared, and univariate and multivariate Logistic regression analysis were used for finding the related factors for left ventricular hypertrophy. Results The serum total bilirubin level was significantly lower in left ventricular hypertrophy group than none left ventricular hypertrophy group [(22.47±6.75) U/L vs. (33.24±5.84) U/L]. The univariate Logistic analysis showed that serum total bilirubin (OR=0.586, 95% CI 0.259-0.852; P=0.001) was a protective factor for left ventricular hypertrophy, while age (OR=1.372, 95% CI 1.103-1.925; P=0.047) and systolic blood pressure (OR=1.569, 95% CI 1.125-2.896; P=0.002) were risk factors. Multiple Logistic analysis showed that serum total bilirubin (OR=0.459, 95% CI 0.231-0759; P=0.018) was still a protective factor for left ventricular hypertrophy. Conclusion Serum total bilirubin is a protective factor for left ventricular hypertrophy, and monitoring the changes of serum total bilirubin may has significant effect on the early detection of left ventricular hypertrophy.

Keywords:Hypertension; Bilirubin; Hypertrophy, left ventricular

+ 字体 -

参考文献

  [1] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志, 2011, 39(7): 579-616.

  [2] Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH) and of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2013, 34(28): 2159-2219.

  [3] Nano J, Muka T, Cepeda M, et al. Association of circulating total bilirubin with the metabolic syndrome and type 2 diabetes: A systematic review and meta-analysis of observational evidence[J]. Diabetes Metab, 2016, S1262(16): 30433-30435.

  [4] Kindo M, Gerelli S, Bouitbir J, et al. Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress[J]. Front Physiol, 2012, 8(3): 332-346.

  [5] Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension(JSH 2009)[J]. Hypertens Res, 2009, 32(1): 3-107.

  [6] Zheng J, Wu Y, Li Z, et al. Low serum total bilirubin concentration was associated with increased high sensitive C reactive protein level in patients with impaired glucose tolerance and type 2 diabetes mellitus subjects[J]. Clin Lab, 2016, 62(5): 901-907.

  [7] Sarda T, Rathod S, Kolte A, et al. Expression of periodontal inflammation into left ventricular hypertrophy in type 2 diabetes mellitus: a cross-sectional study[J]. Contemp Clin Dent, 2016, 7(3): 343-348.

  [8] Bulut C, Helvaci A, Adas M, et al. The relationship between left ventricular mass and insulin resistance in obese patients[J]. Indian Heart J, 2016, 68(4): 507-512.

  [9] Drozdz D, Kwinta P, Sztefko K, et al. Oxidative stress biomarkers and left ventricular hypertrophy in children with chronic kidney disease[J]. Oxid Med Cell Longev, 2016, 2016(1): 7520231-7520239.

  [10] Zhou YD, Cao XQ, Liu ZH, et al. Rapamycin inhibits oxidized low density lipoprotein uptake in human umbilical vein endothelial cells via mTOR/NF-kappaB/LOX-1 pathway[J]. PLoS One, 2016, 11(1): e146777-e146789.

  [11] Maizel J, Xavier S, Chen J, et al. Sirtuin 1 ablation in endothelial cells is associated with impaired angiogenesis and diastolic dysfunction[J]. Am J Physiol Heart Circ Physiol, 2014, 307(12): H1691-H1704.

  [12] Huang YH, Yang YC, Lu FH, et al. Serum bilirubin is inversely associated with increased arterial stiffness in men with pre-hypertension but not normotension[J]. PLoS One, 2016, 11(1): e146226-e146231.

  [13] Gong JN, Zhai ZG, Yang YH, et al. Serum bilirubin and 6-min walk distance as prognostic predictors for inoperable chronic thromboembolic pulmonary hypertension: a prospective cohort study[J]. Chin Med J (Engl), 2015, 128(23): 3125-3131.

  [14] Lian Y, Zhang P, Qin X. Research progress of relationship between serum bilirubin and coronary heart disease[J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2016, 44(1): 76-79.

(编辑:张志巍 收稿日期:2016-11-03)